PF-4800567 is a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), an enzyme involved in the regulation of glucocorticoid levels by catalyzing the conversion of inactive cortisone to active cortisol in tissues. It is primarily utilized in research settings to study the effects of modulating glucocorticoid activity on biological pathways, including metabolic regulation, inflammation, and central nervous system functions. This compound is valuable for understanding the role of 11β-HSD1 in cellular processes and disease mechanisms, particularly in conditions such as type 2 diabetes, obesity, cognitive impairment, depression, and PTSD. Researchers use PF-4800567 to explore potential therapeutic applications, assess efficacy in preclinical models, and validate targets in drug discovery for novel treatments targeting the hypothalamic-pituitary-adrenal (HPA) axis.